Condella Sarah, EVP of Human Resources at Exact Sciences (EXAS), has demonstrated a clear selling bias in her recent insider transactions, with $4.47 million in total sales compared to just $19,617 in purchases across 23 reported trades. Her activity has been exclusively concentrated in EXAS shares, with no recent transactions in other companies. The most significant disposals occurred on December 23, 2025, when she executed multiple sales totaling approximately $3.89 million, including a single transaction valued at $1.63 million. These were followed by additional sales on February 27, 2026, amounting to $197,765.94, alongside a smaller purchase of $19,617 on the same date.
Notably, all of Condella's recent transactions in March 2026 were either derivative dispositions (coded "D") or acquisitions (coded "A") with no reported dollar value, suggesting they may involve option exercises or equity awards rather than open-market trades. The pattern shows consistent divestment of EXAS holdings over time, with the bulk of monetization occurring in late 2025. While her February 2026 purchase represents a minor buy-side exception, the overwhelming weight of her transactions leans toward reducing her position in Exact Sciences. The absence of any recent trades in other securities indicates a focused relationship with her employer's stock.
AI-assisted summary